-CNBC’s “Fast Money: Halftime Report”
Moderna Gets Full Approval Of COVID-19 Vaccine In Canada (Ahead Of US)
Moderna, Inc. (NASDAQ: MRNA) received the first full approval for its COVID-19 vaccine, about eight months after the shot was first accorded emergency use authorization.